RNA, or ribonucleic acid, is a molecule that carries out a remarkably wide range of jobs in your cells. Its most well-known role is acting as a messenger, ferrying genetic instructions from your DNA to the cellular machinery that builds proteins. But RNA does far more than deliver messages. Different types of RNA help construct proteins, regulate which genes are switched on or off, shape how your DNA is packaged, and even catalyze chemical reactions on their own. In medicine, RNA has become both a therapeutic tool and a diagnostic signal for disease.
How RNA Differs From DNA
RNA and DNA are close chemical relatives, but a few structural differences give them very different properties. The sugar backbone of RNA contains an extra oxygen-hydrogen group that DNA lacks. This makes RNA less chemically stable than DNA, which is actually a feature rather than a flaw: RNA is meant to be temporary, carrying out its function and then being broken down so the cell can respond dynamically to changing conditions. RNA also uses the base uracil where DNA uses thymine, and it typically exists as a single strand rather than DNA’s famous double helix. That single-stranded nature lets RNA fold into complex three-dimensional shapes, which is key to many of its functions beyond simple information storage.
Carrying the Genetic Message
The role most people associate with RNA is protein synthesis, and it starts with messenger RNA (mRNA). When your cells need to build a protein, an enzyme reads the relevant stretch of DNA and assembles a complementary mRNA copy in a process called transcription. That mRNA strand then travels out of the nucleus to a ribosome, the cell’s protein-building machine.
At the ribosome, the mRNA is read in groups of three bases at a time. Each three-base group, called a codon, specifies one particular amino acid. The ribosome moves along the mRNA strand, reading codon after codon, and chains the corresponding amino acids together in order. The finished chain folds into a functional protein. This entire sequence, from DNA to mRNA to protein, is the central pipeline of gene expression.
Building and Running the Ribosome
Messenger RNA gets the spotlight, but two other types of RNA do the hands-on work of assembling proteins. Transfer RNA (tRNA) is the adapter molecule. Each tRNA carries a specific amino acid on one end and reads the matching codon on the mRNA with the other. As the ribosome moves along the message, tRNA molecules shuttle in one by one, each delivering its amino acid to the growing protein chain before cycling out to pick up another.
Ribosomal RNA (rRNA) is arguably even more important. It forms the structural core of the ribosome itself and, surprisingly, performs the actual chemistry. The ribosome is what scientists call a ribozyme: an RNA molecule that acts as a catalyst. It is rRNA, not the protein components of the ribosome, that recognizes the correct tRNA, forms the chemical bond linking amino acids together, and physically moves the tRNA and mRNA through the machine during each step. Virtually all of the key contacts between the ribosome and the molecules passing through it are made by ribosomal RNA. Proteins play supporting roles, but the engine is RNA.
Creating Protein Diversity Through Splicing
Before mRNA leaves the nucleus, it goes through an editing step that dramatically expands what your genome can do. The initial RNA copy of a gene, called pre-mRNA, contains both coding segments (exons) and non-coding segments (introns). Introns are cut out, and the remaining exons are spliced together to form the final mRNA. What makes this powerful is that the same pre-mRNA can be spliced in different ways, skipping certain exons or including others, to produce different versions of a protein from a single gene.
This process, called alternative splicing, is a major reason why roughly 25,000 human genes can generate more than 90,000 distinct proteins. Different cell types use different splicing patterns, which is part of how a skin cell and a nerve cell can behave so differently despite carrying identical DNA. The old idea of “one gene, one protein” no longer holds.
Regulating Which Genes Are Active
Some of the most fascinating RNA molecules never get translated into protein at all. Instead, they control other genes. MicroRNAs (miRNAs) and small interfering RNAs (siRNAs) are tiny RNA fragments, typically around 20 to 25 bases long, that silence specific genes. They work by pairing up with a target mRNA through complementary base matching, then recruiting a protein complex that either degrades the mRNA or blocks it from being translated. The small RNA acts as a guide, telling the silencing machinery exactly which message to destroy. This gives cells a fast, precise way to dial gene activity up or down.
Long non-coding RNAs (lncRNAs) operate on an even larger scale. These molecules, which can be thousands of bases long, help control how DNA is physically packaged inside the nucleus. They interact directly with the enzymes that modify the proteins DNA wraps around, either guiding those enzymes to specific locations on the genome or acting as scaffolds to assemble entire regulatory complexes. One well-studied example is Xist, a lncRNA that coats one of the two X chromosomes in female mammals and triggers a cascade of chemical modifications that effectively shuts down most of that chromosome’s genes. LncRNAs can also work as decoys, pulling regulatory enzymes away from certain genes to keep them active.
RNA as the Original Life Molecule
RNA’s ability to both store genetic information and catalyze chemical reactions is at the heart of one of biology’s biggest ideas: the RNA world hypothesis. This theory proposes that before DNA or proteins existed, early life ran entirely on RNA. RNA molecules would have stored hereditary information (the way DNA does now) while also driving the chemical reactions cells needed to survive (the way protein enzymes do now). Over evolutionary time, DNA took over information storage because it is more chemically stable, and proteins took over most catalysis because they are more versatile. RNA was left with a collection of roles that still echo its ancient versatility. The fact that the ribosome, the most fundamental machine in all living cells, is at its core an RNA catalyst is considered strong evidence for this idea.
RNA in Modern Medicine
The medical world has found ways to harness nearly every function of RNA. The most visible example is mRNA vaccines. These work by delivering a synthetic mRNA strand, wrapped in a tiny fat particle for protection, into your muscle cells. Your cells read the mRNA and produce a viral protein (such as the spike protein of a coronavirus). Your immune system recognizes that protein as foreign, mounts a response, and builds memory cells that can fight the real virus if you encounter it later. The mRNA itself is broken down within days, leaving only the immune memory behind.
Beyond vaccines, RNA-based drugs that silence disease-causing genes are now reaching patients. In 2025 alone, the FDA approved three oligonucleotide drugs: two siRNAs and one antisense oligonucleotide. One prevents bleeding episodes in people with hemophilia. Another treats a rare genetic condition called hereditary angioedema. A third addresses familial chylomicronemia syndrome, a dangerous buildup of fats in the blood. All three use a liver-targeting delivery system built around a sugar molecule called GalNAc, which has become the standard approach for getting RNA therapies into the right cells.
RNA as a Diagnostic Tool
Small RNA molecules also show up in blood, saliva, and urine, and their patterns can reveal disease. Circulating microRNAs are especially promising as early cancer biomarkers. Because different cancers alter miRNA levels in characteristic ways, researchers have been able to build diagnostic profiles that identify hard-to-detect cancers like lung, liver, and pancreatic cancer from a simple blood draw. In one landmark study, miRNA expression profiles successfully classified poorly differentiated tumors that conventional mRNA analysis could not. More recent work has combined miRNA screening with machine-learning algorithms to distinguish pancreatic cancer from chronic pancreatitis, a distinction that is notoriously difficult with standard imaging. These approaches are still being refined for routine clinical use, but the stability of miRNAs in body fluids and the sensitivity of modern detection methods make them a strong candidate for non-invasive early screening.